Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:57:32.516Z.
Calculation as of: 2026-10-06T15:57:32.516Z.
Quote observation: 2026-10-06T15:54:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 352cae2fe5eed9f02885becd1bbca6bb54c51239af0254a5780fc03f1b1dafbc
EARNINGS YIELD
N/A
Market Cap
$104.28M
Earnings Yield
N/A
TTM Avg
0.56%
3Y Avg
0.56%
5Y Avg
0.56%
Market Cap
$104.68M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.08M
Earnings Yield
N/A
TTM Avg
0.32%
3Y Avg
0.91%
5Y Avg
2.50%
Market Cap
$108.30M
Earnings Yield
N/A
TTM Avg
9.36%
3Y Avg
9.36%
5Y Avg
9.36%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $103.06M | N/A | N/A | N/A | N/A |
| The Joint Corp. (JYNT)vs › | $103.00M | 3.67% | 2.61% | 2.26% | 1.70% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.28M | N/A | 0.56% | 0.56% | 0.56% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.38M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.08M | N/A | 0.32% | 0.91% | 2.50% |
| PolyPid Ltd. (PYPD)vs › | $99.04M | N/A | N/A | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $98.04M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.30M | N/A | 9.36% | 9.36% | 9.36% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.57M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute